Cargando…
Introduction
Autores principales: | Brixner, Diana I., Oderda, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437802/ http://dx.doi.org/10.18553/jmcp.2012.18.s4-a.S03 |
Ejemplares similares
-
Introduction
por: Brixner, Diana I.
Publicado: (2012) -
Can CER Be an Effective Tool for Change in the Development and Assessment of New Drugs and Technologies?
por: Brixner, Diana I., et al.
Publicado: (2012) -
Bringing Liraglutide to Market: A CER Case Study
por: Oderda, Gary, et al.
Publicado: (2012) -
Comparative Effectiveness Research (CER): A Summary of AHRQ’s CER on Therapies for Rheumatoid Arthritis
por: Oderda, Gary M., et al.
Publicado: (2011) -
Introduction
por: Owens, Gary M.
Publicado: (2013)